Effect of triamcinolone acetonide in trigeminal neuralgia (TN) pain

https://doi.org/10.53730/ijhs.v7nS1.14409

Authors

  • Kashif Adnan BDS, MFDS RCPS (Glasgow), FICD, Demonstrator/ Registrar at de'Montmorency College of Dentistry, Lahore
  • Nayab Tariq BDS, Dow International Dental College, DUHS, Karachi
  • Sana Shakil Khan BDS, FCPS Resident (Oral maxillofacial) at Abbasi Shaheed Hospital, Karachi
  • Amir Abkar Shaikh BDS, DDPH, Professor Community Dentistry Department at Muhammad Dental College, Mirpurkhas
  • Yousuf Moosa BDS, MDS, PhD (Periodontology), Professor at Muhammad Dental College, Mirpurkhas
  • Aahmar Maqsood House Officer at Shaikh Zayed Hospital, Lahore
  • Assad Ullah Veterinary Officer at Civil Veterinary Hospital Gumbat, kohat, KPK-Pakistan

Keywords:

Triamcinolone acetonide, Trigeminal neuralgia, Trigeminal nerve block

Abstract

Background: Trigeminal neuralgia is a form of neuropathic pain caused by trigeminal nerve. Anticonvulsants are primary class of pharmaceuticals used to treat pain in trigeminal neuralgia patients. Another conservative treatment option for controlling this pain includes blocking of nerve. Objectives: To determine how trigeminal neuralgia patients respond to triamcinolone acetonide. Methods: The department of oral and maxillofacial surgery at de'Montmorency College of Dentistry/Punjab dental hospital conducted a cross-sectional study over a six-month period. 35 study participants underwent a clinical examination along with a history-taking process. Written consent was obtained. After gathering the necessary information, the affected nerve was identified followed by the administration of local anesthesia. The most painful area was identified and 5 mL of bupivacaine and 40 mg of triamcinolone acetonide was administered at that side. After five minutes, the participant's level of pain was assessed, and they were contacted back for follow-up after seven days. Every item on the post-op list of targeted goals was checked off in the participant's questionnaire at the follow-up day. With SPSS version 24, the statistical analysis was completed. Results: There were 35 participants in the study overall, with the majority of them being in their 40s or 50s. 

Downloads

Download data is not yet available.

References

Araya, E. I., Claudino, R. F., Piovesan, E. J., & Chichorro, J. G. J. C. N. (2020). Trigeminal neuralgia: basic and clinical aspects. 18(2), 109-119.

Gambeta, E., Chichorro, J. G., & Zamponi, G. W. J. M. p. (2020). Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. 16, 1744806920901890.

Nader, A., Kendall, M. C., DeOliveria, G. S., Chen, J. Q., Vanderby, B., Rosenow, J. M., & Bendok, B. R. J. P. P. (2013). Ultrasound-guided trigeminal nerve block via the pterygopalatine fossa: an effective treatment for trigeminal neuralgia and atypical facial pain. 16(5), E537.

Obermann, M. J. F. (2019). Recent advances in understanding/managing trigeminal neuralgia. 8.

Wasim, M. H., Saleem, S. A., Naqvi, S. A., Hasan, M. N.-u., Durrani, N. A., & Zubair, M. J. C. (2022). Recurrence Rate of Trigeminal Neuralgia With the Use of Percutaneous Stereotactic Continuous Radiofrequency Ablation at 80° C for 90 Seconds: A Single-Center Study. 14(1).

Xu, R., Xie, M. E., & Jackson, C. M. J. J. o. P. R. (2021). Trigeminal neuralgia: current approaches and emerging interventions. 3437-3463.

Yameen, F., Shahbaz, N. N., Hasan, Y., Fauz, R., & Abdullah, M. J. J.-J. o. t. P. M. A. (2011). Efficacy of transcutaneous electrical nerve stimulation and its different modes in patients with trigeminal neuralgia. 61(5), 437.

Published

27-06-2023

How to Cite

Adnan, K., Tariq, N., Khan, S. S., Shaikh, A. A., Moosa, Y., Maqsood, A., & Ullah, A. (2023). Effect of triamcinolone acetonide in trigeminal neuralgia (TN) pain. International Journal of Health Sciences, 7(S1), 1760–1767. https://doi.org/10.53730/ijhs.v7nS1.14409

Issue

Section

Peer Review Articles

Most read articles by the same author(s)